Veradermics MANE
NYSE MANE
$138.49 +1.83 (+1.34%)
As of: Oct 22, 2026 · 3:59 PM EDT

Veradermics (MANE) Cash from Operations (2025 - 2026)

Updated

Veradermics (MANE) reported Cash from Operations of -$14.5 million for Q2 2026, compared with -$15.68 million a year earlier.

Analysis

Veradermics (MANE) Cash from Operations (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Veradermics' Cash from Operations came in at -$64.7 million; for FY2025, it was -$71.6 million.

  • By year, Cash from Operations came in at -$23.7 million in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Cash from Operations since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 7.72 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.44 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.87 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.57 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 835.00 Mn
10 Veradermics 5.63 Bn 4.22 Bn - -14.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.50 Mn
Mar 31, 2026 -21.20 Mn
Jun 30, 2025 -15.68 Mn
Mar 31, 2025 -13.32 Mn
API Access

Veradermics Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=MANE&period=max&api_key=YOUR_API_KEY